[1]
L. Kumar, “PHARMACOVIGILANCE/REPORTING ADVERSE DRUG REACTIONS: AN APPROACH TO ENHANCE HEALTH SURVEILLANCE AND EXTENDING MARKET SHARE BY MINIMIZING THE CHANCES OF DRUG WITHDRAWALS”, Int J Pharm Pharm Sci, vol. 7, no. 9, pp. 1–7, Sep. 2015.